HORMONE AND METABOLIC RESEARCH

Scope & Guideline

Exploring the Interplay of Hormones and Metabolism

Introduction

Delve into the academic richness of HORMONE AND METABOLIC RESEARCH with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0018-5043
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1969 to 2024
AbbreviationHORM METAB RES / Horm. Metab. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

The journal 'HORMONE AND METABOLIC RESEARCH' primarily focuses on advancing the understanding of hormonal interactions and metabolic processes, highlighting both clinical and experimental research. It aims to disseminate significant findings that contribute to the fields of endocrinology and metabolism, exploring various hormonal disorders and their implications on metabolic health.
  1. Endocrine Disorders and Hormonal Regulation:
    The journal extensively covers research related to various endocrine disorders, including thyroid disorders, adrenal insufficiencies, and metabolic syndromes. It aims to elucidate the role of hormones in these conditions and their management.
  2. Metabolic Syndrome and Related Complications:
    Research on metabolic syndrome, including its biochemical markers, risk factors, and associations with other diseases like diabetes and cardiovascular conditions, is a core focus. The journal emphasizes studies that explore the pathophysiological mechanisms underlying these conditions.
  3. Innovative Therapeutic Approaches:
    The journal encourages research that investigates new therapeutic strategies and pharmacological interventions for metabolic and endocrine disorders, including the use of novel drugs and treatment protocols.
  4. Molecular Mechanisms and Biomarkers:
    The journal publishes studies that delve into the molecular pathways involved in hormone regulation and metabolism, identifying potential biomarkers for early diagnosis and prognosis of endocrine and metabolic diseases.
  5. Clinical Implications and Public Health:
    There is a strong emphasis on clinical research that translates findings into practical applications, addressing public health concerns related to metabolic disorders, including obesity, diabetes, and cardiovascular diseases.
The journal has shown a dynamic evolution in its focus, with several emerging themes gaining traction in recent publications. These trends reflect the growing complexities of hormonal and metabolic research and the need for innovative approaches to address current health challenges.
  1. Metabolic Effects of COVID-19:
    Recent articles have focused on the interplay between COVID-19 and metabolic disorders, highlighting how the pandemic has affected patients with pre-existing conditions and the implications for treatment and management.
  2. Role of Gut Microbiome in Metabolism:
    There is an increasing interest in exploring how the gut microbiome influences hormonal regulation and metabolic health, suggesting a shift towards a more integrative approach in understanding metabolism.
  3. Personalized Medicine Approaches:
    Emerging research emphasizes personalized medicine in treating endocrine and metabolic disorders, including the use of genetic and phenotypic information to tailor treatment strategies.
  4. Molecular Pathways in Hormonal Regulation:
    There is a growing trend in investigating the molecular pathways that govern hormonal actions and their impact on various metabolic processes, including the utilization of advanced technologies like metabolomics and genomics.
  5. Integration of Digital Health Technologies:
    The incorporation of digital health technologies and telemedicine into the management of metabolic disorders is becoming a prominent theme, reflecting a broader shift in healthcare delivery systems.

Declining or Waning

While 'HORMONE AND METABOLIC RESEARCH' continues to cover a broad range of topics, some areas of research appear to be declining in prominence. This may reflect shifts in research focus or changes in clinical priorities within the field.
  1. Traditional Hormone Replacement Therapies:
    Research related to conventional hormone replacement therapies has seen a decline, possibly due to the emergence of newer, more targeted therapies that offer improved outcomes and safety profiles.
  2. Older Metabolic Syndrome Definitions:
    The journal has published fewer studies focused on outdated definitions and diagnostic criteria for metabolic syndrome, as the field moves towards more refined and clinically relevant classifications.
  3. Single Hormone Studies:
    There has been a noticeable decrease in publications that focus solely on the effects of individual hormones without considering their interactions within the broader endocrine system and metabolic pathways.
  4. Animal Model Studies:
    Research utilizing traditional animal models for metabolic and endocrine diseases is less prevalent, possibly due to a shift towards human clinical trials and translational research that better reflects human physiology.
  5. Epidemiological Studies with Limited Scope:
    There is a waning interest in epidemiological studies that lack comprehensive data or fail to address broader implications of findings within the context of public health and clinical practice.

Similar Journals

Nature Reviews Endocrinology

Empowering researchers with critical reviews.
Publisher: NATURE PORTFOLIOISSN: 1759-5029Frequency: 12 issues/year

Nature Reviews Endocrinology is a premier journal published by NATURE PORTFOLIO, providing comprehensive and critical reviews in the rapidly evolving field of endocrinology. Established to foster advanced understanding, it has become a vital resource for researchers, professionals, and students alike. With an impressive impact factor and a prominent ranking of Q1 in both Endocrinology and Endocrinology, Diabetes, and Metabolism categories for 2023, the journal is recognized for its high-quality research dissemination, evidenced by its rankings of #2 out of 244 in Medicine and #2 out of 128 in Biochemistry, Genetics, and Molecular Biology. Spanning the years from 2009 to 2024, it focuses on publishing cutting-edge information that shapes current scientific knowledge and clinical practices. The journal offers open access options, ensuring greater visibility and reach for its articles. Located in Germany, this journal remains at the forefront of endocrinology research, significantly contributing to the understanding of hormonal functions and their implications on health. Discover the latest advancements and insights by exploring Nature Reviews Endocrinology.

BMC Endocrine Disorders

Exploring breakthroughs in endocrine health and disorders.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

International Journal of Endocrinology and Metabolism

Elevating Knowledge in Endocrine Science
Publisher: BRIEFLANDISSN: 1726-913XFrequency: 4 issues/year

The International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.

Turkish Journal of Endocrinology and Metabolism

Pioneering Open Access Discoveries in Metabolism and Endocrinology
Publisher: AVESISSN: 1301-2193Frequency: 4 issues/year

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Connecting research and practice in physiological sciences.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Unveiling breakthroughs in metabolism and diabetes.
Publisher: SPRINGERISSN: 1389-9155Frequency: 6 issues/year

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

ANNALES D ENDOCRINOLOGIE

Exploring Hormonal Frontiers: Insights from 1946 to Today
Publisher: MASSON EDITEURISSN: 0003-4266Frequency: 6 issues/year

ANNALES D ENDOCRINOLOGIE is a prestigious academic journal dedicated to the vibrant field of endocrinology, encompassing key aspects of diabetes and metabolism. Published by MASSON EDITEUR, this journal has been a vital resource for researchers and healthcare professionals since its inception in 1946. With its impressive Q2 ranking in the Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) categories, it showcases a wealth of high-quality research, reviews, and contributions that push the boundaries of endocrinological science. Although not open access, the journal maintains a significant impact on the academic community, with ongoing discussion and dissemination of pivotal advancements. The comprehensive coverage from 1946 to 2024 ensures that a broad spectrum of hormonal disorders, therapeutic innovations, and metabolic health issues are thoroughly explored, reflecting its commitment to enhancing knowledge and clinical practice in endocrinology. By engaging with this journal, researchers, clinicians, and students alike can stay informed of the latest trends and discoveries within the endocrine field.

Journal of the Endocrine Society

Transforming knowledge into clinical practice in endocrinology.
Publisher: ENDOCRINE SOCISSN: Frequency: 12 issues/year

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Empowering Knowledge for Young Lives
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

Frontiers in Endocrinology

Empowering Science Through Open Access in Endocrinology
Publisher: FRONTIERS MEDIA SAISSN: 1664-2392Frequency: 1 issue/year

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.